Cytodyn Inc (CYDY)

[Leronlimab4DaWin]

10K due today!

1) Looks like uplist is gone
2) Stock has been very weak since they reported results, which indicated they didn't meet their primary endpoint. Which means, per the FDA, due to multiplicity and alpha spend, the secondary endpoints cannot be statsig. Every biotech investor knows this, which is why they are pressing their shrots.
3) Nader knows he will not meet any endpoint in moderate/severe so he is pumping the EUA. However, everyone knows since Leronlimab missed its primary endpoint, per the FDA, due to multiplicity and alpha spend, the secondary endpoints cannot be statsig; therefore, EUA will never happen.
4) Here comes $0.20